PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Kollias, G.* ; Papadaki, P.* ; Apparailly, F.* ; Vervoordeldonk, M.J.* ; Holmdahl, R.* ; Baumans, V.* ; Desaintes, C.* ; di Santo, J.* ; Distler, J.* ; Garside, P.* ; Hegen, M.* ; Huizinga, T.W.* ; Jüngel, A.* ; Klareskog, L.* ; McInnes, I.* ; Ragoussis, I.* ; Schett, G.* ; Hart, B.* ; Tak, P.P.* ; Toes, R.* ; van den Berg, W.* ; Wurst, W. ; Gay, S.*

Animal models for arthritis: Innovative tools for prevention and treatment.

Ann. Rheum. Dis. 70, 1357-1362 (2011)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The development of novel treatments for rheumatoid arthritis (RA) requires the interplay between clinical observations and studies in animal models. Given the complex molecular pathogenesis and highly heterogeneous clinical picture of RA, there is an urgent need to dissect its multifactorial nature and to propose new strategies for preventive, early and curative treatments. Research on animal models has generated new knowledge on RA pathophysiology and aetiology and has provided highly successful paradigms for innovative drug development. Recent focus has shifted towards the discovery of novel biomarkers, with emphasis on presymptomatic and emerging stages of human RA, and towards addressing the pathophysiological mechanisms and subsequent efficacy of interventions that underlie different disease variants. Shifts in the current paradigms underlying RA pathogenesis have also led to increased demand for new (including humanised) animal models. There is therefore an urgent need to integrate the knowledge on human and animal models with the ultimate goal of creating a comprehensive 'pathogenesis map' that will guide alignment of existing and new animal models to the subset of disease they mimic. This requires full and standardised characterisation of all models at the genotypic, phenotypic and biomarker level, exploiting recent technological developments in 'omics' profiling and computational biology as well as state of the art bioimaging. Efficient integration and dissemination of information and resources as well as outreach to the public will be necessary to manage the plethora of data accumulated and to increase community awareness and support for innovative animal model research in rheumatology.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.082
2.487
43
77
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter tumor-necrosis-factor; collagen-induced arthritis; rheumatoid-arthritis; monoclonal-antibody; biologic therapies; factor cachectin; factor-alpha; disease; mice; autoimmunity
Sprache englisch
Veröffentlichungsjahr 2011
HGF-Berichtsjahr 2011
ISSN (print) / ISBN 0003-4967
e-ISSN 1468-2060
Zeitschrift Annals of the Rheumatic Diseases : ARD online
Quellenangaben Band: 70, Heft: 8, Seiten: 1357-1362 Artikelnummer: , Supplement: ,
Verlag BMJ Publishing Group
Verlagsort London, UK
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Developmental Genetics (IDG)
POF Topic(s) 30204 - Cell Programming and Repair
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500500-001
PubMed ID 21628308
DOI 10.1136/ard.2010.148551
Erfassungsdatum 2011-09-15
[➜Korrektur melden]